Retrospective analysis reveals no reduction in acute kidney injury risk after cardiac surgery with SGLT2 inhibitors, suggesting need for further investigation.
Preoperative exposure to SGLT2i was not associated with a reduction in cardiac surgery-associated acute kidney injury in the present study, which was underpowered to rule out a potential clinically significant effect.
No takes yet. Share an insight, caveat, or question.
Ruste et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: